newsfilter
← Latest News
Business Wire·

NeoGenomics Announces Settlement of Voluntary Disclosure to OIG-HHS

  • NeoGenomics, Inc. finalized a civil settlement with the U.S. Department of Justice on behalf of the HHS Office of Inspector General regarding an investigation into its Laboratory Collaboration Initiative consulting services.
  • The Company self-disclosed the matter to the OIG in November 2021 & cooperated fully with the government's investigation.
  • NeoGenomics agreed to pay $9,813,260 plus interest at a rate of 4.250% per annum from January 16, 2026, to resolve the matter.
  • The Company previously accrued a reserve of $11.2 million in SEC filings to cover potential liabilities associated with the investigation.
  • The settlement agreement explicitly states that it is not an admission of liability by the Company nor a concession by the United States regarding the validity of its claims.
  • CEO Tony Zook stated the resolution allows the Company to move forward with its vision to advance personalized cancer care.
  • NeoGenomics is a cancer diagnostics company headquartered in Fort Myers, FL, operating CAP-accredited laboratories in the U.S. & one in Cambridge, UK.